According the news source, the drug maker plans to close the plant in phases over a period of three years. The closure of the plant is expected to eliminate approximately 260 jobs.
Shire reportedly plans to outsource the drug manufacturing operations that were previously done at the plant to a contract manufacturer based in North Carolina, US. The drug maker hopes to market the space and is believed to be in talks with Baltimore County Department of Economic Development for finding potential takers for the manufacturing site.